Select Page

Hydrus™ Microstent 2-Year Results

Image Source: www.ivantisinc.com CAUTION: INVESTIGATIONAL DEVICE. LIMITED TO INVESTIGATIONAL USE IN THE UNITED STATES. There may soon be another Minimally Invasive Glaucoma Surgery (MIGS) available in the USA. The Hydrus™ Microstent (Ivantis, Irvine, CA), described in...

EyeOP1® Ultrasound Cyclo-Plasty (UCP) Glaucoma Treatment

EyeOP1® Ultrasound Cyclo-Plasty (UCP) In late October it was announced that the Chinese FDA (but not yet the American FDA) had approved a new non-invasive glaucoma treatment called EyeOP1® Ultrasound Cyclo-Plasty (also known as Ultrasound Ciliary-Plasty, or UCP)....

VYZULTA™: A New FDA Approved Glaucoma Medication with Dual Action

On November 2, 2017, the FDA approved VYZULTA™ (latanoprostene bunod 0.024%) for the treatment of glaucoma. This newly available medication treats glaucoma in two distinct ways. One of these methods of protecting the optic nerve has already been available to those...

Pin It on Pinterest

SiteLock